Senior Postdoctoral Research Assistant in Immunology
| Dyddiad hysbysebu: | 23 Chwefror 2026 |
|---|---|
| Cyflog: | £49,119 i £58,265 bob blwyddyn |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 16 Mawrth 2026 |
| Lleoliad: | Kennedy Institute of Rheumatology, Roosevelt Drive, Headington, Oxford OX3 7FY |
| Gweithio o bell: | Ar y safle yn unig |
| Cwmni: | University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences |
| Math o swydd: | Dros dro |
| Cyfeirnod swydd: | 184983 |
Crynodeb
The University of Oxford is a stimulating work environment, which enjoys an international reputation as a world-class centre of excellence. Our research plays a key role in tackling many global challenges, from reducing our carbon emissions to developing vaccines during a pandemic.
The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) is part of the Medical Sciences Division and is the largest European academic department in its field, running a globally competitive programme of research and teaching. The Kennedy Institute is a biomedical research centre uniquely bringing together discovery science and early-stage clinical research, to develop transformative new therapies for chronic inflammatory and musculoskeletal conditions.
The Experimental Medicine Collaboration (EMC) collaboration combines the outstanding drug discovery, target validation and clinical development of GSK with Oxford’s exceptional track record in the research and development of new drug therapies and Oxford’s Old Road Campus Experimental Medicine capabilities, and particularly the Experimental Medicine Clinical Research Facility (EMCRF) (https://www.kennedy.ox.ac.uk/news/oxford-and-gsk-launch-experimental-medicine-collaboration). This will allow testing of multiple medicines across cellular mechanisms in parallel, ensuring accelerated assessment of existing and new therapies. Improving our understanding of the cellular basis of disease will help bridge the gap between drug development and trial delivery.
What We Offer
As an employer, we genuinely care about our employees’ wellbeing and this is reflected in the range of benefits that we offer including:
• An excellent contributory pension scheme
• 38 days annual leave
• A comprehensive range of childcare services
• Family leave schemes
• Cycle loan scheme
• Discounted bus travel and Season Ticket travel loans
• Membership to a variety of social and sports clubs
About the Role
We are offering an exciting and unique opportunity for an experienced postdoctoral researcher to work at the interface of academia and industry. The post-holder will be the Oxford-based wet lab postdoc for the Experimental Medicine Collaboration (EMC) collaboration working under the supervision of EMCRF Director Prof Chris Buckley and will closely collaborate with other team members in Oxford such as Tissue Biology Lead Dr Matthias Friedrich, Computational/Bioinformatics Lead Dr Calliope Dendrou, Data Management Lead Prof Brian Marsden, Data Sharing/Visualisation Lead Dr Stephen Taylor, and multiple GSK colleagues.
About You
You will hold a PhD in Immunology or a related area with post-qualification research experience as well as a strong publication record and familiarity with the existing literature and research in the field. You will have experience of independently managing a research project together with evidence of having collaborated with both wet and dry lab researchers to complete a project. You will have a keen interest in experimental medicine and immune-mediated inflammatory disease and demonstrate experience in standard laboratory-based immunology techniques, such as human tissue handling and culture, PCR, flow cytometry.
Application Process
You will be required to upload a covering letter/supporting statement, CV and the details of two referees as part of your online application. Please quote 184983 in all correspondence.
The closing date for applications is 12pm 16th March 2026.
Interviews will take place during week commencing 30th March or 6th April 2026 and will be online.
The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) is part of the Medical Sciences Division and is the largest European academic department in its field, running a globally competitive programme of research and teaching. The Kennedy Institute is a biomedical research centre uniquely bringing together discovery science and early-stage clinical research, to develop transformative new therapies for chronic inflammatory and musculoskeletal conditions.
The Experimental Medicine Collaboration (EMC) collaboration combines the outstanding drug discovery, target validation and clinical development of GSK with Oxford’s exceptional track record in the research and development of new drug therapies and Oxford’s Old Road Campus Experimental Medicine capabilities, and particularly the Experimental Medicine Clinical Research Facility (EMCRF) (https://www.kennedy.ox.ac.uk/news/oxford-and-gsk-launch-experimental-medicine-collaboration). This will allow testing of multiple medicines across cellular mechanisms in parallel, ensuring accelerated assessment of existing and new therapies. Improving our understanding of the cellular basis of disease will help bridge the gap between drug development and trial delivery.
What We Offer
As an employer, we genuinely care about our employees’ wellbeing and this is reflected in the range of benefits that we offer including:
• An excellent contributory pension scheme
• 38 days annual leave
• A comprehensive range of childcare services
• Family leave schemes
• Cycle loan scheme
• Discounted bus travel and Season Ticket travel loans
• Membership to a variety of social and sports clubs
About the Role
We are offering an exciting and unique opportunity for an experienced postdoctoral researcher to work at the interface of academia and industry. The post-holder will be the Oxford-based wet lab postdoc for the Experimental Medicine Collaboration (EMC) collaboration working under the supervision of EMCRF Director Prof Chris Buckley and will closely collaborate with other team members in Oxford such as Tissue Biology Lead Dr Matthias Friedrich, Computational/Bioinformatics Lead Dr Calliope Dendrou, Data Management Lead Prof Brian Marsden, Data Sharing/Visualisation Lead Dr Stephen Taylor, and multiple GSK colleagues.
About You
You will hold a PhD in Immunology or a related area with post-qualification research experience as well as a strong publication record and familiarity with the existing literature and research in the field. You will have experience of independently managing a research project together with evidence of having collaborated with both wet and dry lab researchers to complete a project. You will have a keen interest in experimental medicine and immune-mediated inflammatory disease and demonstrate experience in standard laboratory-based immunology techniques, such as human tissue handling and culture, PCR, flow cytometry.
Application Process
You will be required to upload a covering letter/supporting statement, CV and the details of two referees as part of your online application. Please quote 184983 in all correspondence.
The closing date for applications is 12pm 16th March 2026.
Interviews will take place during week commencing 30th March or 6th April 2026 and will be online.